Bangalore, Sept. 4 (PTI): Biotechnology firm Bharat Biotech International (BBIL) has announced the launch of BioHib, the first indigenously developed and manufactured Haemophilus Influenza Type B (Hib) vaccine in India, and Comvac 4-HB, a tetravalent combination vaccine.
